The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A single-arm trial of panitumumab in cetuximab refractory KRAS wild-type colorectal cancer.
Raymond C. Wadlow
Disclosure not yet available
Aram F. Hezel
Disclosure not yet available
Brian M. Wolpin
Disclosure not yet available
Jill N. Allen
Disclosure not yet available
Lawrence S. Blaszkowsky
Disclosure not yet available
Eunice Lee Kwak
Disclosure not yet available
Rui Wang
Disclosure not yet available
Andrew X. Zhu
Disclosure not yet available
David P. Ryan
Disclosure not yet available
Jeffrey W. Clark
Disclosure not yet available